Research ArticleHuman Studies
Testicular Function in Patients with Differentiated Thyroid Carcinoma Treated with Radioiodine
Furio Pacini, Maurizio Gasperi, Laura Fugazzola, Claudia Ceccarelli, Francesco Lippi, Roberta Centoni, Enio Martino and Aldo Pinchera
Journal of Nuclear Medicine September 1994, 35 (9) 1418-1422;
Furio Pacini
Maurizio Gasperi
Laura Fugazzola
Claudia Ceccarelli
Francesco Lippi
Roberta Centoni
Enio Martino


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Testicular Function in Patients with Differentiated Thyroid Carcinoma Treated with Radioiodine
Furio Pacini, Maurizio Gasperi, Laura Fugazzola, Claudia Ceccarelli, Francesco Lippi, Roberta Centoni, Enio Martino, Aldo Pinchera
Journal of Nuclear Medicine Sep 1994, 35 (9) 1418-1422;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Complications of Radioactive Iodine Treatment of Thyroid Carcinoma
- Preparation with Recombinant Human Thyroid-Stimulating Hormone for Thyroid Remnant Ablation with 131I Is Associated with Lowered Radiotoxicity
- European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.
- Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
- Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report
- The Evolving Role of 131I for the Treatment of Differentiated Thyroid Carcinoma